Neurologic complications are not uncommon following bariatric surgery. Hyperammonemic encephalopathy (HAE) due to an acquired or unmasked urea cycle deficit is among the rarest of these. Pediatric nutrition support specialists are familiar with recognizing urea cycle deficits, but adult specialists may not be. Here we present a case of a patient initially misdiagnosed with cirrhosis who presented with recurrent HAE 4 years after Roux-en-Y gastric bypass. She was diagnosed with a proximal urea cycle deficit and severe protein calorie malnutrition. The patient recovered with specialized nutrition and medical support targeting this condition. A literature review indicates multiple fatalities from this condition, indicating the importance of early diagnosis and appropriate nutrition support.
CelloJPRogersSJ. Morbid obesity-the new pandemic: medical and surgical management, and implications for the practicing gastroenterologist. Clin Transl Gastroenterol. 2013;4:e35.
2.
SamuelIMasonEERenquistKEHuangYHZimmermanMBJamalM. Bariatric surgery trends: an 18-year report from the International Bariatric Surgery Registry. Am J Surg. 2006;192:657-662.
3.
LeeSCarmodyBWolfeL. Effect of location and speed of diagnosis on anastomotic leak outcomes in 3828 gastric bypass cases. J Gastrointest Surg. 2007;11:708-713.
ShiffmanMLSugermanHJKellumJMBrewerWHMooreEW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol. 1991;86:1000-1005.
KaplanLM. Gastrointestinal management of the bariatric surgery patient. Gastroenterol Clin North Am. 2005;34:105-125.
8.
LevitzkyBEWassefWY. Endoscopic management in the bariatric surgical patient. Curr Opin Gastroenterol. 2010;26:632-639.
9.
MonteroPNStefanidisDNortonHJGersinKKuwadaT. Reported excess weight loss after bariatric surgery could vary significantly depending on calculation method: a plea for standardization. Surg Obes Relat Dis. 2011;7:531-534.
10.
LimketkaiBNZuckerSD. Hyperammonemic encephalopathy caused by carnitine deficiency. J Gen Intern Med. 2008;23:210-213.
11.
WhiteJVGuenterPJensenGMaloneASchofieldM. Consensus statement of the academy of nutrition and dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet. 2012;112:730-738.
12.
EstrellaJYeeGWilckenBTchanMTalbotM. Hyperammonemic encephalopathy complicating bariatric surgery: a case study and review of the literature. Surg Obes Relat Dis. 2014;10:e35-e38.
13.
FenvesABolandCRLepeRRivera-TorresPSpechlerSJ. Fatal hyperammonemic encephalopathy after gastric bypass surgery. Am J Med. 2008;121:e1-e2.
14.
HuWTKantarciOHMerrittJLII. Ornithine transcarbamylase deficiency presenting as encephalopathy during adulthood following bariatric surgery. Arch Neurol. 2007;64:126-128.
15.
McCulloughBAYudkoffMBatshawMLWilsonJMRaperSETuchmanM. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet. 2000;93:313-319.
16.
TuchmanMMorizonoHRajagopalBSPlanteRJAllewellNM. The biochemical and molecular spectrum of ornithine transcarbamylase deficiency. J Inherit Metab Dis. 1998;21(suppl 1):40-58.
ArnPHHauserERThomasGHHermanGHessDBrusilowSW. Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus: a cause of postpartum coma. N Engl J Med. 1990;322:1652-1655.
EllawayCJBennettsBTuckRRWilckenB. Clumsiness, confusion, coma, and valproate. Lancet. 1999;353:1408.
21.
ThakurVRuparCARamsayDASinghRFraserDD. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid. Pediatr Crit Care Med. 2006;7:273-276.
22.
GidalBEIngleseCMMeyerJFPitterleMEAntonopolousJRustRS. Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine. Pediatr Neurol. 1997;16:301-305.
23.
DuarteJMaciasSCoriaFFernandezEClaveriaLE. Valproate-induced coma: case report and literature review. Ann Pharmacother. 1993;27:582-583.
24.
ClayASHainlineBE. Hyperammonemia in the ICU. Chest. 2007;132:1368-1378.
25.
VaqueroJChungCCahillMEBleiAT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis. 2003;23:259-270.
26.
ShawcrossDJalanR. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005;62:2295-2304.
27.
BachmannC. Mechanisms of hyperammonemia. Clin Chem Lab Med. 2002;40:653-662.
28.
CostellMO’ConnorJEMiguezMPGrisoliaS. Effects of L-carnitine on urea synthesis following acute ammonia intoxication in mice. Biochem Biophys Res Commun. 1984;120:726-733.
29.
Lexicomp. L-carnitine drug information [online]. Accessed 2014.
30.
AquilioESpagnoliRRiggioDSeriS. Effects of zinc on hepatic ornithine transcarbamylase (OTC) activity. J Trace Elem Electrolytes Health Dis. 1993;7:240-241.
31.
ChoiDELeeKWShinYTNaKR. Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency. J Korean Med Sci. 2012;27:556-559.
32.
World Health Organization. Protein and Amino Acid Requirements in Human Nutrition. World Health Organization technical report series. Geneva, Switzerland: World Health Organization; 2007.
33.
HaberleJBoddaertNBurlinaA. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32.
34.
SummarM. Current strategies for the management of neonatal urea cycle disorders. J Pediatr. 2001;138:S30-S39.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
